InvestorsHub Logo
Followers 0
Posts 5690
Boards Moderated 0
Alias Born 06/09/2012

Re: bbking2003 post# 7130

Wednesday, 03/26/2014 8:27:33 AM

Wednesday, March 26, 2014 8:27:33 AM

Post# of 717223
This was quite a good point:


Also, The DCVax-L Phase III trial has an unusual element in that 33 patients were enrolled and treated 2006-2008, so there is data from that subset giving a long term view into results.



That is a good % of those treated offering a long view look. Should bode well with the FDA I'm sure. Hmm..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News